111 related articles for article (PubMed ID: 27817842)
1. [Pregabalin-induced parkinsonism: A case report].
Masmoudi I; Gras-Champel V; Barbieux-Vaquez D; Masmoudi K
Therapie; 2017 Jun; 72(3):395-396. PubMed ID: 27817842
[No Abstract] [Full Text] [Related]
2. A Case of Pregabalin-Induced Parkinsonism.
Ari BC; Domac FM; Kenangil GO
Neurol India; 2020; 68(6):1469-1471. PubMed ID: 33342895
[TBL] [Abstract][Full Text] [Related]
3. Valproate-induced parkinsonism: use of a newer pharmacovigilance tool to investigate the reporting of an unanticipated adverse event with an "old" drug.
Hauben M; Reich L
Mov Disord; 2005 Mar; 20(3):387. PubMed ID: 15641014
[No Abstract] [Full Text] [Related]
4. [Reversible parkinsonism induced by prolonged treatment with valproate].
Barroso B
Therapie; 2002; 57(4):410-1. PubMed ID: 12422564
[No Abstract] [Full Text] [Related]
5. A case of severe parkinsonism in an elderly person induced by valproic acid.
Tada H; Ogihara T; Nakamura T; Sasayama D; Sugiyama N; Takahashi Y; Washizuka S; Amano N
Psychogeriatrics; 2017 Jan; 17(1):76-77. PubMed ID: 26757408
[No Abstract] [Full Text] [Related]
6. Phenytoin-induced parkinsonism.
Ertan S; Ulu MO; Hanimoglu H; Tanriverdi T; Kafadar AM; Acar ZU; Kiziltan G
Singapore Med J; 2006 Nov; 47(11):981-3. PubMed ID: 17075669
[TBL] [Abstract][Full Text] [Related]
7. Could pregabalin cause oculomotor symptoms in lower dose? A case with down beat nystagmus as a side effect.
Ekinci AS; Ciftci S; Cavus B; Aydogdu I
Acta Neurol Belg; 2017 Sep; 117(3):777-778. PubMed ID: 27988831
[No Abstract] [Full Text] [Related]
8. [Drug abuse of pregabalin - state of the situation, risks and means of control].
Laribi M; Chaouali N; Jaballah S; Amira D; Hedhili A
Ann Pharm Fr; 2023 May; 81(3):419-424. PubMed ID: 36375531
[TBL] [Abstract][Full Text] [Related]
9. [Reversible Parkinsonism and cognitive impairment following treatment with valproate].
Toribio-Díaz ME; Morera-Guitart J; Palao-Duarte S
Rev Neurol; 2008 Oct 1-15; 47(7):390-1. PubMed ID: 18841554
[No Abstract] [Full Text] [Related]
10. [Reversible dementia-like condition and parkinsonism in an elderly woman. Idiosyncratic adverse effects connected to 11 years of antiepileptic medication].
Lindbom U; Taubert B; Fahlqvist MS; Bergens A; Kimland E; Jonsson EW; Bergman U
Lakartidningen; 2009 Mar 18-24; 106(12):863-5. PubMed ID: 19452788
[No Abstract] [Full Text] [Related]
11. Valproate-induced parkinsonism, glial cells and Alexander's disease.
Sechi GP; Conti M; Sau GF; Cocco GA
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1351-2. PubMed ID: 18495313
[No Abstract] [Full Text] [Related]
12. [Pregabalin Dependence: A Case Report].
Aldemir E; Altıntoprak AE; Coşkunol H
Turk Psikiyatri Derg; 2015; 26(3):217-20. PubMed ID: 26364177
[TBL] [Abstract][Full Text] [Related]
13. Valproate-induced Parkinsonism in epilepsy patients.
Jamora D; Lim SH; Pan A; Tan L; Tan EK
Mov Disord; 2007 Jan; 22(1):130-3. PubMed ID: 17115396
[TBL] [Abstract][Full Text] [Related]
14. Use of Pregabalin - A Nationwide Pharmacoepidemiological Drug Utilization Study with Focus on Abuse Potential.
Schjerning O; Pottegård A; Damkier P; Rosenzweig M; Nielsen J
Pharmacopsychiatry; 2016 Jul; 49(4):155-61. PubMed ID: 26951495
[TBL] [Abstract][Full Text] [Related]
15. Parkinsonism and/or cognitive impairment with valproic acid therapy: a report of ten cases.
Masmoudi K; Gras-Champel V; Masson H; Andréjak M
Pharmacopsychiatry; 2006 Jan; 39(1):9-12. PubMed ID: 16453247
[TBL] [Abstract][Full Text] [Related]
16. Unilateral hemorrhagic macular infarction associated with marijuana, alcohol and antiepileptic drug intake.
Aktaş S; Tetikoğlu M; İnan S; Aktaş H; Özcura F
Cutan Ocul Toxicol; 2017 Mar; 36(1):88-95. PubMed ID: 26912022
[TBL] [Abstract][Full Text] [Related]
17. Epilepsy, parkinsonism, and neuroleptic malignant syndrome in a child.
Martínez HR; Cantú-Martínez L; González HC; Flores Lde L; Villarreal HJ; Onofre-Castillo J
J Child Neurol; 2006 Dec; 21(12):1073-5. PubMed ID: 17156702
[TBL] [Abstract][Full Text] [Related]
18. Pregabaline as a Rare Cause of Hepatotoxicity.
Düzenli T; Ata E; Kösem M; Bayram Çarli A
Pain Med; 2017 Jul; 18(7):1407-1408. PubMed ID: 28087846
[No Abstract] [Full Text] [Related]
19. [Neuropsychiatric symptoms caused by valproic acid].
Andrade R; García-Espinosa A; Pérez-Montoto A; Toledo-Sotomayor G; Remón-González Y; Frades-García V
Rev Neurol; 2010 Jan 1-15; 50(1):62-3. PubMed ID: 20073028
[No Abstract] [Full Text] [Related]
20. Influence of arachidonyl-2'-chloroethylamide, a selective cannabinoid CB1 receptor agonist, on the anticonvulsant and acute side-effect potentials of clobazam, lacosamide, and pregabalin in the maximal electroshock-induced seizure model and chimney test in mice.
Florek-Luszczki M; Zagaja M; Luszczki JJ
Fundam Clin Pharmacol; 2015 Aug; 29(4):382-93. PubMed ID: 25904357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
